Aspivix

Switzerland
Renens, Vaud, Switzerland, 1020

Company profile

Aspivix company profile

ASPIVIX is developing a new generation of medical devices that make gynecological procedures gentler and safer for women and gynecologists. The first device, CAREVIX, is designed to prevent cervix bleeding using a suction technology to replace traumatic tenaculum (forceps).

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
1020
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
15
Total equity funding
$8.7M
Last funding
Debt Financing / $556,435 / 2024-06-27
Last equity funding
Series A / $5M
Investors
12
Lead investors
6
Founders
3
Articles
44

Founders and investors

Founders

David FinciJulien FinciMathieu Horras

Lead investors

4FO VenturesFoundation for Innovation and Technology (FIT)HemexInnosuisseInnovaudVenture Kick

Investors

InnosuisseInnovaudMassChallengeVenture KickZürcher Kantonal Bank